Evansbrook’s Procter & Gamble PG Stock Holding History

Evansbrook’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Sell	6,660 -3	-0%	-$437	0.58%	35
2026 Q1	$962K	Buy	6,663 +145	+2%	+$22K	0.64%	34
2025 Q4	$934K	Buy	+6,518	New	+$961K	0.62%	35

Other funds holding PG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Evansbrook's PG Position: Q2 2026 in Review

Evansbrook reduced its Procter & Gamble (PG) stake by 0.05% in Q2 2026, selling an estimated $437 and leaving 6,660 shares worth $977K. The position accounts for 0.58% of the portfolio, ranked #35.

Evansbrook first reported a position in PG in Q4 2025 and has held it in 3 quarters since. 4,013 funds tracked by Wall St. Rank hold PG as of Q2 2026.

Evansbrook held 6,660 shares of Procter & Gamble worth $977K as of Q2 2026.
Evansbrook sold 3 Procter & Gamble shares in Q2 2026, an estimated $437.
Procter & Gamble made up 0.58% of Evansbrook's portfolio in Q2 2026, its #35 holding.
Evansbrook first reported a position in Procter & Gamble in Q4 2025 and has held it in 3 quarters since.
4,013 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Evansbrook's 13F filing for Q2 2026, filed 4 Aug 2026.